Skip to content

Spread of Medication During Continuous Thoracic Paravertebral Block

Spread of Medication During Continuous Thoracic Paravertebral Block

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078442
Enrollment
Unknown
Registered
2023-12-08
Start date
2023-12-10
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic Neuralgia

Interventions

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age =18 years, =80 years, gender is not limited; 2) Meet the diagnostic criteria of postherpetic neuralgia, and the lesion segment is T1-12. 3) Patients voluntarily signed an informed consent form and were able to cooperate in completing the treatment and questionnaire survey.

Exclusion criteria

Exclusion criteria: Patients with abnormal spinal anatomy or paravertebral structures indicated by physical or imaging examinations. Patients who have undergone paravertebral treatment or spinal surgery. Patients with drug allergies used in this study; Combined systemic diseases, such as systemic infections, tumors, hematological disorders, severe heart, lung, liver, kidney dysfunction, coagulation disorders, etc; Individuals with skin damage or local infection at the puncture site; claustrophobia Patients (including accompanying family members) who have installed or carried the following items and devices in their bodies, including: pacemakers, defibrillators, heart stents, artificial heart valves, metal clips after aneurysm surgery, drug infusion devices implanted in the body, any electronic devices implanted in the body, divine meridian stimulators, bone growth stimulators, any other type of biological stimulators, endovascular embolization coils, filters, inferior vena cava filters Electrocardiogram monitoring devices, metal sutures, presence of bullets, fragments or iron particles in the body, fixation of steel plates, screws, screws, artificial limbs or joints, penile prostheses, hearing aids, cochlear implants, middle ear implants, intraocular metal foreign bodies, artificial eyes, removable dentures, dental braces, and implants in the head and face after fracture surgery. Patients who are unable to cooperate with the examination. Patients who are unable to undergo nerve block or magnetic resonance imaging due to combined psychological and psychological factors or other reasons

Design outcomes

Primary

MeasureTime frame
The spread of medication;

Secondary

MeasureTime frame
Pain Accessment;The spread of sensory block;Mood Accessment;sleep assessment;Clinical efficacy;The success rate of block;Safty Accessment;

Countries

China

Contacts

Public ContactZhang Wei

Shanghai East Hospital

hey_zhangwei@126.com+86 198 5537 5047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026